224 related articles for article (PubMed ID: 11193669)
21. Evaluation of a frozen trivalent attenuated vaccine against Babesiosis and anaplasmosis in Brazil.
Vidotto O; Barbosa CS; Andrade GM; Machado RZ; da Rocha MA; Silva SS
Ann N Y Acad Sci; 1998 Jun; 849():420-3. PubMed ID: 9668502
[No Abstract] [Full Text] [Related]
22. Exoantigens of an attenuated strain of Babesia bovis used as a vaccine against bovine babesiosis.
Patarroyo JH; Prates AA; Tavares CA; Mafra CL; Vargas MI
Vet Parasitol; 1995 Oct; 59(3-4):189-99. PubMed ID: 8533277
[TBL] [Abstract][Full Text] [Related]
23. Artemisone inhibits in vitro and in vivo propagation of Babesia bovis and B. bigemina parasites.
Mazuz ML; Golenser J; Fish L; Haynes RK; Wollkomirsky R; Leibovich B; Shkap V
Exp Parasitol; 2013 Dec; 135(4):690-4. PubMed ID: 24184077
[TBL] [Abstract][Full Text] [Related]
24. Bovine babesiosis: induction of protective immunity with culture-derived Babesia bovis and Babesia bigemina immunogens.
Montenegro-James S; Toro Benitez M; Leon E; Lopez R; Ristic M
Parasitol Res; 1987; 74(2):142-50. PubMed ID: 3325981
[TBL] [Abstract][Full Text] [Related]
25. Emerging perspectives in the research of bovine babesiosis and anaplasmosis.
Suarez CE; Noh S
Vet Parasitol; 2011 Aug; 180(1-2):109-25. PubMed ID: 21684084
[TBL] [Abstract][Full Text] [Related]
26. Advances in the development of molecular tools for the control of bovine babesiosis in Mexico.
Mosqueda J; Figueroa JV; Alvarez A; Bautista R; Falcon A; Ramos A; Canto G; Vega CA
Parassitologia; 2007 May; 49 Suppl 1():19-22. PubMed ID: 17691602
[TBL] [Abstract][Full Text] [Related]
27. Overcoming constraints to meeting increased demand for Babesia bigemina vaccine in Australia.
Standfast NF; Bock RE; Wiecek MM; deVos AJ; Jorgensen WK; Kingston TG
Vet Parasitol; 2003 Jul; 115(3):213-22. PubMed ID: 12935736
[TBL] [Abstract][Full Text] [Related]
28. Attenuated trivalent vaccine against babesiosis and anaplasmosis in Colombia.
Benavides E; Vizcaino O; Britto CM; Romero A; Rubio A
Ann N Y Acad Sci; 2000; 916():613-6. PubMed ID: 11193685
[No Abstract] [Full Text] [Related]
29. Immunoprophylactic control of bovine babesiosis: role of exoantigens of Babesia.
Montenegro-James S
Trans R Soc Trop Med Hyg; 1989; 83 Suppl():85-94. PubMed ID: 2696166
[TBL] [Abstract][Full Text] [Related]
30. Field evaluation of an exoantigen-containing Babesia vaccine in Venezuela.
Montenegro-James S; Toro M; Leon E; Guillen AT
Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():283-8. PubMed ID: 1343704
[TBL] [Abstract][Full Text] [Related]
31. Unravelling the cellular and molecular pathogenesis of bovine babesiosis: is the sky the limit?
Suarez CE; Alzan HF; Silva MG; Rathinasamy V; Poole WA; Cooke BM
Int J Parasitol; 2019 Feb; 49(2):183-197. PubMed ID: 30690089
[TBL] [Abstract][Full Text] [Related]
32. Efficiency of a recombinant MSA-2c-based ELISA to establish the persistence of antibodies in cattle vaccinated with Babesia bovis.
Bono MF; Mangold AJ; Baravalle ME; Valentini BS; Thompson CS; Wilkowsky SE; Echaide IE; Farber MD; Torioni de Echaide SM
Vet Parasitol; 2008 Nov; 157(3-4):203-10. PubMed ID: 18783887
[TBL] [Abstract][Full Text] [Related]
33. Attenuated vaccines for tropical theileriosis, babesiosis and heartwater: the continuing necessity.
Shkap V; de Vos AJ; Zweygarth E; Jongejan F
Trends Parasitol; 2007 Sep; 23(9):420-6. PubMed ID: 17656155
[TBL] [Abstract][Full Text] [Related]
34. Babesia bovis: analysis of and preliminary vaccination studies with a defined infected erythrocyte membrane binding antigen.
Goodger BV; Waltisbuhl DJ; Wright IG; White M
Int J Parasitol; 1992 Jul; 22(4):533-5. PubMed ID: 1644530
[TBL] [Abstract][Full Text] [Related]
35. Immunity following use of Australian tick fever vaccine: a review of the evidence.
Bock RE; de Vos AJ
Aust Vet J; 2001 Dec; 79(12):832-9. PubMed ID: 11837905
[TBL] [Abstract][Full Text] [Related]
36. Development of a Babesia bovis live attenuated vaccine.
Alonso M; Blandino T; Mendoza E; Savon L; Camacho M
Arch Med Res; 1994; 25(2):273-7. PubMed ID: 7919825
[TBL] [Abstract][Full Text] [Related]
37. Search for Babesia bovis vaccine candidates.
Florin-Christensen M; Schnittger L; Dominguez M; Mesplet M; RodrÃguez A; Ferreri L; Asenzo G; Wilkowsky S; Farber M; Echaide I; Suarez C
Parassitologia; 2007 May; 49 Suppl 1():9-12. PubMed ID: 17691600
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the infectivity of a vaccinal and a pathogenic Babesia bovis strain from Argentina to Boophilus microplus.
Mangold AJ; Aguirre DH; Cafrune MM; de Echaide ST; Guglielmone AA
Vet Parasitol; 1993 Dec; 51(1-2):143-8. PubMed ID: 8128578
[TBL] [Abstract][Full Text] [Related]
39. Viability after thawing and dilution of simultaneously cryopreserved vaccinal Babesia bovis and Babesia bigemina strains cultured in vitro.
Mangold AJ; Vanzini VR; Echaide IE; de Echaide ST; Volpogni MM; Guglielmone AA
Vet Parasitol; 1996 Feb; 61(3-4):345-8. PubMed ID: 8720572
[TBL] [Abstract][Full Text] [Related]
40. Heterologous strain immunity in bovine babesiosis using a culture-derived soluble Babesia bovis immunogen.
Montenegro-James S; Ristic M; Toro Benitez M; Leon E; Lopez R
Vet Parasitol; 1985 Dec; 18(4):321-37. PubMed ID: 4090242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
